Zio AT ECG Monitoring System vs Us2.ai
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Zio AT is an AI-powered wearable system focused on continuous ECG monitoring for arrhythmia detection over an extended period. In contrast, Us2.ai is an AI software designed to automate the analysis of echocardiograms for structural and functional cardiac condition detection. While both tools operate within cardiology AI, they address different diagnostic modalities and clinical workflows, making them complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
The Zio AT ECG Monitoring System is designed for long-term, continuous ECG monitoring to detect arrhythmias and symptomatic/asymptomatic cardiac events. In contrast, Us2.ai automates the analysis of echocardiograms to detect various cardiac conditions like amyloidosis, heart failure, aortic stenosis, and pulmonary hypertension, and generates structured reports.
The Zio AT system uses a wearable Zio AT patch for continuous ECG recording and a wireless gateway for real-time data transmission, with an FDA-cleared AI algorithm (ZEUS System) for arrhythmia detection. Us2.ai processes existing echocardiogram images in real-time to perform fully automated analysis and generate structured reports.
The Zio AT system focuses on detecting symptomatic and asymptomatic cardiac events and arrhythmias through continuous ECG monitoring. Us2.ai automates the detection of cardiac conditions such as cardiac amyloidosis, heart failure, aortic stenosis, and pulmonary hypertension from echocardiograms.
The Zio AT system provides a ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation, along with a MyZiou00ae patient mobile app for symptom logging. Us2.ai is designed for integration with PACS, CVIS, EMR, and ultrasound devices using DICOM and HL7 standards, delivering zero-click structured reports.
The Zio AT system provides comprehensive end-of-wear reports for clinicians based on up to 14 days of continuous ECG recording. Us2.ai generates fully automated, zero-click structured reports with comprehensive measurements (2D, Doppler, M-mode, strain analysis) and automated disease detection, adhering to international guidelines.
More Comparisons
Backers
Who funded each tool's parent company.